Pharmacological modulation of eosinophil influx into the lungs of Brown Norway rats

European Journal of Pharmacology
M T NamovicR L Bell

Abstract

A model of lung inflammation was developed in Brown Norway rats. Intense lung eosinophilia was induced by a single intravenous injection of Sephadex G-200 particles. The eosinophilia observed was preceded by an increase in cysteinyl leukotrienes found in lung lavage fluids. Theophylline and albuterol were tested in the model and found to be inactive, while dexamethasone was effective. Zileuton, a specific leukotriene inhibitor, was found to effectively inhibit leukotriene formation and the influx of eosinophils into the lungs of these Sephadex-treated animals. Studies with specific leukotriene D4 antagonists of the cysLT1 type receptor indicate that this leukotriene receptor is probably not involved directly in the eosinophilic inflammation. This model appears to be useful in characterizing potential anti-inflammatory effects of inhibitors by evaluating their ability to prevent eosinophil influx into the lung.

References

May 29, 1975·The New England Journal of Medicine·B R HornA Van Kessel
Jan 1, 1992·International Archives of Allergy and Immunology·W ElwoodK F Chung
Dec 1, 1990·British Journal of Pharmacology·B A SpicerH Smith
Jan 1, 1991·Annals of the New York Academy of Sciences·W J CalhounW W Busse
May 1, 1991·The Journal of Allergy and Clinical Immunology·A B Kay
Apr 1, 1990·The American Review of Respiratory Disease·R D KrellF J Brown
Jan 1, 1986·International Archives of Allergy and Applied Immunology·S M LaycockB A Spicer
Apr 1, 1986·The Journal of Allergy and Clinical Immunology·E Frigas, G J Gleich
Dec 1, 1974·Cellular Immunology·R A Schriber, D Zucker-Franklin
Jun 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·R S Walls, P B Beeson
Feb 1, 1982·The Journal of Experimental Medicine·A JörgS J Klebanoff
Nov 1, 1993·Agents and Actions·P RossiJ G Martin
Feb 1, 1995·Canadian Journal of Physiology and Pharmacology·T R JonesP Masson
Feb 1, 1995·International Journal of Immunopharmacology·R R HarrisD W Brooks
Sep 1, 1995·American Journal of Respiratory and Critical Care Medicine·S E WenzelJ Y Westcott
Nov 1, 1994·Annals of Internal Medicine·W R Henderson

❮ Previous
Next ❯

Citations

Aug 7, 1999·Clinical Reviews in Allergy & Immunology·R L Bell, R R Harris
Oct 18, 2003·The Journal of Allergy and Clinical Immunology·Shigeo MuroWilliam S Powell
Jun 5, 2003·International Immunopharmacology·Yukio SugimotoChiaki Kamei
Aug 2, 2000·American Journal of Respiratory Cell and Molecular Biology·K J SerioT D Bigby
Dec 17, 1998·The Journal of Clinical Investigation·P StamatiouW S Powell
Mar 31, 2011·Journal of Leukocyte Biology·Mari KogisoYoshimi Shibata
Sep 19, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·Kenneth J SerioJenny T Mao
Feb 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kenneth J SerioTimothy D Bigby
Apr 17, 2021·ACS Pharmacology & Translational Science·Thomas W FlanaganCharles D Nichols
Feb 15, 2001·The Journal of Allergy and Clinical Immunology·W S PowellJ Rokach
Feb 26, 2000·Journal of Medicinal Chemistry·T KolasaC D Brooks

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here